OSCR - NYSE
Oscar Health, Inc.
$20.50
-0.44%Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
At a Glance
Live SnapshotOscar Health, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.
Debt-to-Equity Ratio
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Working Capital
Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Financial Health Insight
Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.
Oscar Health, Inc. Balance Sheet
OSCR • NYSE
| Oscar Health, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
2.8B | 1.5B | 1.9B | 1.6B | 1.1B | 826.3M | 336.6M | |
1.2B | 624.5M | 689.8M | 1.4B | 587.1M | 366.4M | 333.8M | |
4B | 2.2B | 2.6B | 3B | 1.7B | 1.2B | 670.4M | |
442.6M | 315.9M | 494.4M | 49.9M | 611.1M | 96.5M | 55.2M | |
442.6M | 251.1M | 442.5M | 216.5M | 570.4M | 65.3M | 30.1M | |
0.0 | 64.8M | 51.9M | 49.9M | 40.7M | 31.2M | 25.1M | |
180.1M | 377.6M | -983M | 1.1B | 463.9M | -1.3B | -725.6M | |
4.6B | 2.8B | 2.1B | 4.1B | 2.8B | 0.0 | 0.0 | |
NON-CURRENT ASSETS | |||||||
88.4M | 66.8M | 61.9M | 59.9M | 46.6M | 35.8M | 33.1M | |
1.5B | 1.8B | 365.3M | 1.4B | 844.5M | 366.4M | 333.8M | |
152.7M | 113.3M | 1.1B | -1.1B | -335.4M | -402.2M | -366.8M | |
1.7B | 2B | 1.5B | 405M | 555.6M | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3B | 1.3B | |
6.3B | 4.8B | 3.6B | 4.5B | 3.3B | 2.3B | 1.3B | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
-99.8M | 3B | 2.1B | 2.9B | 1.5B | 1.4B | 887.7M | |
-99.8M | 1.4B | 1B | 1.4B | 718.8M | 655.2M | 589.1M | |
0.0 | 1.6B | 1.1B | 1.5B | 794.4M | 716.4M | 298.6M | |
0.0 | 0.0 | 0.0 | 0.0 | 75M | 0.0 | 0.0 | |
5B | 215.3M | -2.3B | 381.1M | 29.2M | -1.4B | -887.7M | |
4.9B | 3.2B | -175.3M | 3.3B | 1.6B | 0.0 | 0.0 | |
NON-CURRENT LIABILITIES | |||||||
430.1M | 299.6M | 298.8M | 298M | 0.0 | 142.5M | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 4.1M | 0.0 | 0.0 | |
52M | 61.3M | 2.7B | 72.3M | 2.3B | -142.5M | 0.0 | |
482.1M | 360.8M | 3B | 370.3M | 2.3B | 0.0 | 0.0 | |
0.0 | 291.5M | 0.0 | 0.0 | 0.0 | 3.6B | 2.3B | |
5.3B | 3.8B | 2.8B | 3.6B | 1.9B | 3.6B | 2.3B | |
SHAREHOLDERS' EQUITY | |||||||
-2.9M | -2.9M | -2.9M | -2.9M | -2.9M | -2.9M | -2.9M | |
3K | 2K | 2K | 2K | 2K | 2K | 2K | |
4.3B | 3.9B | 3.7B | 3.5B | 3.4B | 133.3M | 70.7M | |
-3.3B | -2.9B | -2.9B | -2.6B | -2B | -1.4B | -1B | |
18M | -1.8M | 1.3M | -9.7M | -3.7M | 879K | -27K | |
977.6M | 1B | 804M | 890.4M | 1.4B | -1.3B | -945.1M | |
980.7M | 1B | 806.1M | 892.4M | 1.4B | -1.3B | -945.1M | |
3.1M | 2.8M | 2.2M | 2M | 5.3M | 0.0 | 0.0 | |
SUMMARY | |||||||
6.3B | 4.8B | 3.6B | 4.5B | 3.3B | 2.3B | 1.3B | |
2.7B | 2.4B | 1.1B | 2.8B | 1.4B | 692.1M | 363.2M | |
430.1M | 299.6M | 298.8M | 298M | 0.0 | 142.5M | 0.0 | |
-2.3B | -1.2B | -1.6B | -1.3B | -1.1B | -683.8M | -336.6M | |
255,419,000 | 255,419,000 | 255,419,000 | 255,419,000 | 255,419,000 | 255,419,000 | 255,419,000 |
SEC Filings
OSCR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | May 29, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 21, 2026 | April 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 13, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 06, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 29, 2025 | December 22, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 03, 2025 | 2025 |
Related Guides
Continue your OSCR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.